These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34901861)

  • 1. Immune Signatures of Treatment-Resistant Schizophrenia: A FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Study.
    Leboyer M; Godin O; Terro E; Boukouaci W; Lu CL; Andre M; Aouizerate B; Berna F; Barau C; Capdevielle D; Clauss-Kobayashi J; Chereau I; D Amato T; Dubertret C; Dubreucq J; Fond G; Laouamri H; Leignier S; Lancon C; Llorca PM; Mallet J; Le Corvoisier P; Misdrahi D; Passerieux C; Rey R; Pignon B; Urbach M; Szoke A; Schürhoff F; Tamouza R;
    Schizophr Bull Open; 2021 Jan; 2(1):sgab012. PubMed ID: 34901861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort.
    Fond G; Godin O; Boyer L; Berna F; Andrianarisoa M; Coulon N; Brunel L; Bulzacka E; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Schürhoff F; Leboyer M;
    Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):985-992. PubMed ID: 29808267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine in Treatment-Resistant Schizophrenia and Its Augmentation with Electroconvulsive Therapy in Ultra-Treatment-Resistant Schizophrenia.
    Peitl V; Puljić A; Škrobo M; Nadalin S; Fumić Dunkić L; Karlović D
    Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice].
    Schürhoff F; Fond G; Berna F; Bulzacka E; Godin O; Boyer L; Misdrahi D; Andrianarisoa M; Brunel L; Coulon N; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Mallet J; Rey R; Lancon C; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Llorca PM;
    Encephale; 2019 Feb; 45(1):9-14. PubMed ID: 30327207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards an improved access to psychiatric rehabilitation: availability and effectiveness at 1-year follow-up of psychoeducation, cognitive remediation therapy, cognitive behaviour therapy and social skills training in the FondaMental Advanced Centers of Expertise-Schizophrenia (FACE-SZ) national cohort.
    Dubreucq J; Ycart B; Gabayet F; Perier CC; Hamon A; Llorca PM; Boyer L; Godin O; Bulzacka E; Andrianarisoa M; Aouizerate B; Berna F; Brunel L; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Faget C; Mallet J; Misdrahi D; Passerieux C; Rey R; Richieri R; Schandrin A; Schürhoff F; Urbach M; Vidailhet P; Giraud-Baro E; Fond G;
    Eur Arch Psychiatry Clin Neurosci; 2019 Aug; 269(5):599-610. PubMed ID: 30963264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohort.
    Fond G; Bulzacka E; Boucekine M; Schürhoff F; Berna F; Godin O; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; ; Boyer L; Llorca PM
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():8-18. PubMed ID: 30552914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in the association of treatment-resistant schizophrenia and serum interleukin-6 levels.
    He J; Wei Y; Li J; Tang Y; Liu J; He Z; Zhou R; He X; Ren H; Liao Y; Gu L; Yuan N; Chen X; Tang J
    BMC Psychiatry; 2023 Jun; 23(1):470. PubMed ID: 37370004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.
    Fond G; Resseguier N; Schürhoff F; Godin O; Andrianarisoa M; Brunel L; Bulzacka E; Aouizerate B; Berna F; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Lançon C; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Boyer L; Leboyer M;
    Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):541-553. PubMed ID: 29127503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort.
    Misdrahi D; Tessier A; Daubigney A; Meissner WG; Schurhoff F; Boyer L; Godin O; Bulzacka E; Aouizerate B; Andrianarisoa M; Berna F; Capdevielle D; Chereau-Boudet I; D'Amato T; Dubertret C; Dubreucq J; Faget-Agius C; Lançon C; Mallet J; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Fond G;
    J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30695288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort.
    Foiselle M; Barbosa S; Godin O; Wu CL; Boukouaci W; Andre M; Aouizerate B; Berna F; Barau C; Capdevielle D; Vidailhet P; Chereau I; Davidovic L; Dorey JM; Dubertret C; Dubreucq J; Faget C; Fond G; Leigner S; Llorca PM; Mallet J; Misdrahi D; Martinuzzi E; Passerieux C; Rey R; Pignon B; Urbach M; Schürhoff F; Glaichenhaus N; Leboyer M; Tamouza R;
    Brain Behav Immun Health; 2022 Jul; 22():100436. PubMed ID: 35469211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort.
    Fond G; Godin O; Schürhoff F; Berna F; André M; Aouizerate B; Capdevielle D; Chereau I; D' Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Szoke A; Urbach M; Vidailhet P; Leboyer M; Boyer L; Llorca PM;
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109927. PubMed ID: 32173456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra-treatment resistant schizophrenia.
    Costa-Dookhan KA; Rajji TK; Tran VN; Bowden S; Mueller DJ; Remington GJ; Agarwal SM; Hahn MK
    Sci Rep; 2021 Jan; 11(1):2004. PubMed ID: 33479273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort.
    Mallet J; Le Strat Y; Schürhoff F; Mazer N; Portalier C; Andrianarisoa M; Aouizerate B; Berna F; Brunel L; Capdevielle D; Chereau I; D'Amato T; Denizot H; Dubreucq J; Faget C; Gabayet F; Lançon C; Llorca PM; Misdrahi D; Rey R; Roux P; Schandrin A; Urbach M; Vidailhet P; Fond G; Dubertret C;
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):332-339. PubMed ID: 28663115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables.
    de Bartolomeis A; Prinzivalli E; Callovini G; D'Ambrosio L; Altavilla B; Avagliano C; Iasevoli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():356-366. PubMed ID: 28887181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients.
    Iasevoli F; D'Ambrosio L; Notar Francesco D; Razzino E; Buonaguro EF; Giordano S; Patterson TL; de Bartolomeis A
    Schizophr Res; 2018 Dec; 202():217-225. PubMed ID: 29934250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory disequilibrium and lateral ventricular enlargement in treatment-resistant schizophrenia.
    Chen W; Gou M; Wang L; Li N; Li W; Tong J; Zhou Y; Xie T; Yu T; Feng W; Li Y; Chen S; Tian B; Tan S; Wang Z; Pan S; Luo X; Zhang P; Huang J; Tian L; Li CR; Tan Y
    Eur Neuropsychopharmacol; 2023 Jul; 72():18-29. PubMed ID: 37058967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set.
    Fond G; Berna F; Boyer L; Godin O; Brunel L; Andrianarisoa M; Aouizerate B; Capdevielle D; Chereau I; Danion JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Gloahec T; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Portalier C; Roux P; Vehier A; Yazbek H; Schürhoff F; Bulzacka E;
    Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):17-26. PubMed ID: 28349247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications.
    Ali FT; Abd El-Azeem EM; Hamed MA; Ali MAM; Abd Al-Kader NM; Hassan EA
    Schizophr Res; 2017 Oct; 188():98-109. PubMed ID: 28100419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.
    de Bartolomeis A; Balletta R; Giordano S; Buonaguro EF; Latte G; Iasevoli F
    Psychiatry Res; 2013 Dec; 210(2):387-95. PubMed ID: 23910239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia.
    Asevedo E; Rizzo LB; Gadelha A; Mansur RB; Ota VK; Berberian AA; Scarpato BS; Teixeira AL; Bressan RA; Brietzke E
    Physiol Behav; 2014 Apr; 129():194-8. PubMed ID: 24576679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.